Inserm Transfert and MassBio announce a partnership to foster innovation, technology transfer and entrepreneurship between France and Massachusetts (USA)
February 6, 2013, Paris (France) and Cambridge, Massachusetts (USA) – Today Inserm Transfert and MassBio announced a partnership aimed at facilitating scientific and commercial interactions between research laboratories and R&D companies in the field of Life Sciences both at Inserm in France and in Massachusetts.
Inserm Transfert will join MassBio programs such as MassCONNECT and the MassBio Innovation Exchange. Conversely MassBio members will have the opportunity to attend events sponsored or promoted by Inserm Transfert in France. The overall goal is to promote scientific collaborations and facilitate the translation of early stage innovation into commercial products for the benefit of patients.
The partnership was spearheaded by Dr. Bernard Malfroy-Camine, a French American biotech entrepreneur, formerly Inserm researcher and a Massachusetts resident for over two decades, who advises Inserm Transfert for US partnerships.
“When it comes to science and innovation, we believe it is extremely important to think international. Pairing our efforts with Massachussetts’ long standing track record in technology transfer was thus a tremendous opportunity, both for our scientists and our young companies” commented Cécile Tharaud, CEO, Inserm Transfert.
“Our new partnership with Inserm Transfert, developed through our Global Gateways initiative, will bring the vibrant clusters of innovation in Massachusetts and France together,” said Robert K. Coughlin, President & CEO of MassBio. “We are pleased to offer our members opportunities for collaborations and partnerships with top-notch early-stage companies from France as we continue to build the global life sciences network.”
About Inserm Transfert
Founded in 2000, InsermTransfert SA is the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), dedicated to technology transfer (from invention disclosure to industrial partnership). InsermTransfert also manages European and International research projects, supports large scale projects in epidemiology and public health. Inserm Transfert runs a 2M€/year proof of concept fund. The company also supports entrepreneurs in the biotech sector, in partnership with Inserm Transfert Initiative, a € 39.7m life sciences seed investment company.
MassBio, a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry, is the nation's oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing the development of critical new science, technology and medicines that benefit people worldwide. Representing over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, MassBio works to advance policy and promote education, while providing member programs and events, industry information, and services.